Skip to content
HowShorted

Corbus Pharmaceuticals Holdings, Inc. short interest in 2020

In 2020, Corbus Pharmaceuticals Holdings, Inc.'s disclosed short interest ran from 23.73% of shares outstanding on 15 Jan 2020 to 19.23% on 31 Dec 2020, a change of -4.50 percentage points. The year's high was 45.85% on 30 Oct 2020 and its low 15.38% on 29 May 2020, averaging 25.04% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.49 days on 31 Jan 2020. Full history: Corbus Pharmaceuticals Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Corbus Pharmaceuticals Holdings, Inc. in 2020

2020 in figures

Start of year
23.73% (15 Jan 2020)
End of year
19.23% (31 Dec 2020)
Change
-4.50 pp
High
45.85% (30 Oct 2020)
Low
15.38% (29 May 2020)
Average
25.04%
Highest days to cover
23.49 (31 Jan 2020)
SEC filings marked
8

Every report in 2020

Corbus Pharmaceuticals Holdings, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202023.73%22.21
31 Jan 202023.54%23.49
14 Feb 202021.99%11.88
28 Feb 202022.77%14.29
13 Mar 202020.18%15.10results (8-K)
31 Mar 202017.41%11.3810-K filed
15 Apr 202017.70%18.88
30 Apr 202016.39%15.82
15 May 202016.27%14.2210-Q filed, results (8-K)
29 May 202015.38%9.58
15 Jun 202015.76%7.85
30 Jun 202018.43%7.32
15 Jul 202019.27%11.10
31 Jul 202018.97%10.03
14 Aug 202019.60%9.8610-Q filed, results (8-K)
31 Aug 202019.14%9.16
15 Sep 202022.40%1.87
30 Sep 202042.49%5.01
15 Oct 202042.95%6.64
30 Oct 202045.85%12.68
13 Nov 202041.70%8.8610-Q filed, results (8-K)
30 Nov 202042.04%13.78
15 Dec 202037.67%5.45
31 Dec 202019.23%1.77

See also: Corbus Pharmaceuticals Holdings, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.